Mounjaro Side Effects and Hair Loss: What's Actually Happening

Step 1: Understanding why rapid weight loss triggers shedding

Hair grows in cycles. The resting phase, known as telogen, normally accounts for around ten to fifteen per cent of your hair at any one time. When your body experiences significant physical stress (surgery, illness, rapid weight change, or a sharp drop in calorie intake) a larger-than-usual proportion of follicles enter telogen simultaneously. The result, two to four months later, is a noticeable increase in shed hairs.

This process is called telogen effluvium. It has been documented in people losing weight through calorie restriction long before GLP-1 medicines existed. The NHS notes hair loss as a reported side effect of tirzepatide, and the Mounjaro Summary of Product Characteristics on the eMC lists alopecia among side effects observed in clinical trials. Critically, the follicles themselves are not permanently damaged. The hair cycle restarts, and regrowth generally follows.

Tirzepatide's appetite-suppressing effect can mean some people eat considerably less than before, particularly in the early months of treatment. If total food intake falls sharply, protein intake often drops alongside it, and that nutritional shortfall can compound the shedding. Think of it this way: the follicle is a metabolically active structure that prioritises its own energy last.

You can read more about the broader pattern on our Mounjaro hair loss overview, which covers the biology in more depth.

Step 2: Recognising what's typical versus what needs attention

Most hair loss associated with tirzepatide is diffuse (spread evenly across the scalp) and seasonal in the sense that it peaks and then gradually eases. It is not the same as male-pattern or female-pattern baldness, and it is not chemotherapy-level loss. Many people notice it when washing or brushing rather than from a visible thinning in the mirror.

In clinical trial data, alopecia occurred in a small proportion of participants. The NHS tirzepatide medicine page confirms hair loss as a known side effect, placing it in the less-common category. If you are wondering whether hair loss is truly a side effect of Mounjaro, our dedicated page looks at what the evidence says and how commonly it occurs. The experience varies considerably between individuals: some notice very little change; others find the shedding genuinely distressing.

Factors that can influence severity include the pace of weight loss, whether protein intake has been maintained, pre-existing nutritional deficiencies (iron and ferritin in particular), thyroid function, and hormonal status. Women may notice it more acutely, especially around dose increases; there is a dedicated page covering how hair loss from Mounjaro affects women if that applies to you.

Shedding that begins before you have lost any significant weight, or that appears in distinct bald patches rather than as diffuse thinning, is not typical of telogen effluvium and should be assessed by a clinician promptly.

Step 3: Practical steps that may help

There is no treatment proven to prevent telogen effluvium specifically in the context of GLP-1 medicines. What is well established, however, is that maintaining nutritional adequacy reduces the additional pressure on follicles.

Protein is the most important lever. Most UK nutritional guidance suggests aiming for at least 0.8g per kilogram of body weight daily, and many clinicians working in this area suggest higher intakes during active weight loss. Eggs in the morning, a portion of fish or legumes at lunch, Greek yoghurt as a snack, small adjustments that help the follicle cycle keep running. A daily multivitamin covering iron, zinc, and biotin may also be worth discussing with your prescriber, particularly if blood tests suggest a deficiency.

Gentle hair-care habits matter too: avoid excessive heat, tight styles that pull the scalp, or harsh chemical treatments during the period of active shedding. Some people find storing their pen in the fridge door alongside their morning routine serves as a useful prompt to also take a protein-forward breakfast, one small habit anchored to another.

Our full Mounjaro side effects guide covers the broader side-effect profile, and our prescribers discuss individual concerns, including hair changes, as part of every consultation. If you are considering treatment or already taking tirzepatide and have questions, speaking to our prescribers is the right starting point.

When to get medical help (and how to report side effects

Contact a clinician or your GP promptly if:

• hair loss is occurring in patches (alopecia areata pattern) rather than as diffuse thinning;
• shedding continues beyond twelve months without any sign of slowing;
• you have other symptoms alongside hair loss) fatigue, sensitivity to cold, changes in weight outside what you expect, that could indicate a thyroid or nutritional cause;
• hair loss is causing significant distress or affecting your quality of life.

Hair loss is not among the side effects that require emergency care, but dismissing it without a proper look at potential contributing factors is also the wrong approach. If your hair changes began during Mounjaro treatment, that is relevant clinical information your prescriber should have, and our page on hair loss from Mounjaro goes into detail about causes, timelines, and what you can do.

You can report any suspected side effect of a medicine you are taking (including hair shedding) using the MHRA's Yellow Card reporting scheme. Patients and carers can report directly, and doing so helps regulators build a fuller picture of how medicines behave in real-world use.

If you have questions about whether Mounjaro is suitable for you, or how our prescribers approach managing side effects like this one, our FAQs page covers many of the questions people ask before starting treatment, including queries about mood swings that some people notice on Mounjaro.